Develop Supply Chain Strategy

April 6, 2016 227

shire

Description
As one of the world’s leading specialty biopharma-ceutical companies, Shire is organized into three divisions: Specialty, Human Genetic Therapies, and Regenerative Medicine.

Opportunities
Since Shire’s formation just over 25 years ago, they have become one of the world’s leading specialty biopharmaceutical companies. Given this growth path, Shire is in the process of preparing its international supply chains to facilitate the internal & external business trends as expected in the 5 years to come.

Solution
Groenewout developed the SC strategy through a 3-step approach:

  1. Provide a framework for the strategic issues and opportunities (costs reductions, customer service improvements & reliability) for the coming 5 years in Shire’s supply chains, based on actual Shire data.
  2. Provide a detailed business case for each of the costs & service opportunities as identified, consisting of operational expenses , capital expenses , customer service impact and business risks.
  3. A toll-gate review for each of the business cases, and actual implementation of the positively evaluated business cases.

Benefits

  • Increased throughput capacity of the supply chains network
  • Reduction of logistics costs, whilst servicing stricter lead-times
Twitter
  • Aandacht voor werkomstandigheden vergroot de waarde van logistiek vastgoed. Meer weten? Lees het artikel https://t.co/23wnyP3uy3 2 weeks ago
  • RT  @HVBMVastgoed : De hobby van Mari van Kuijk  @Groenewout_com  levert mooie #drone beelden op! #hollister #roosendaal https://t.co/8rr1tjz8Y6 4 weeks ago
  • Dataspecialist Rob Wijnen schrijft over 'Meer halen uit magazijndata zonder dure tools' op Logistiek https://t.co/qwbAydN5q8 1 month ago
Unique Selling Points
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.

Start typing and press Enter to search